Bugu da ƙari, zama ainihin tattaunawa na kurame, ya zama labari marar iyaka! Abin mamaki ne...
-
LAFIYA: Babu vaping don yaye taba bisa ga sabon ra'ayi na HCSP
LAFIYA: Babu vaping don yaye taba bisa ga sabon ra'ayi na HCSP
-
TATTALIN ARZIKI: Imperial Brands yana ganin ribar sa ta ragu da kashi 20% saboda vape.
TATTALIN ARZIKI: Imperial Brands yana ganin ribar sa ta ragu da kashi 20% saboda vape.
-
COVID-19: Shan taba ba maganin warkewa bane akan coronavirus!
COVID-19: Shan taba ba maganin warkewa bane akan coronavirus!
-
TATTALIN ARZIKI: Kasuwar Taba ta Amurka ta faɗi, Tabar sigari ta ƙasar Sin ta yi nasara a IPO!
TATTALIN ARZIKI: Kasuwar Taba ta Amurka ta faɗi, Tabar sigari ta ƙasar Sin ta yi nasara a IPO!
-
TATTALIN ARZIKI: Ƙaruwar riba ga Tabar Japan a cikin kwata na farko
TATTALIN ARZIKI: Ƙaruwar riba ga Tabar Japan a cikin kwata na farko
-
TATTALIN ARZIKI: Taba ta Amurka ta Biritaniya ta haifar da fam biliyan 6 na riba
TATTALIN ARZIKI: Taba ta Amurka ta Biritaniya ta haifar da fam biliyan 6 na riba
-
TATTALIN ARZIKI: Imperial Brands za su zuba jarin Yuro miliyan 115 a cikin sigari ta blue.
TATTALIN ARZIKI: Imperial Brands za su zuba jarin Yuro miliyan 115 a cikin sigari ta blue.
-
TATTALIN ARZIKI: Tabar Japan tana sake duba hasashenta zuwa ƙasa.
TATTALIN ARZIKI: Tabar Japan tana sake duba hasashenta zuwa ƙasa.
-
UNITED STATES: Ma'aunin fa'ida mara kyau na e-cigare!
UNITED STATES: Ma'aunin fa'ida mara kyau na e-cigare!
-
E-CIGARETTE: Kyakkyawan fa'ida / haɗarin haɗari bisa ga bita na Cochrane.
E-CIGARETTE: Kyakkyawan fa'ida / haɗarin haɗari bisa ga bita na Cochrane.
-
NAZARI: Fiye da fa'idodi fiye da haɗarin sigari e-cigare
NAZARI: Fiye da fa'idodi fiye da haɗarin sigari e-cigare